News Conference News TCT 2019 Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease Michael O'Riordan September 25, 2019
News Conference News ESC 2019 New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL Michael O'Riordan September 05, 2019
News Conference News ESC 2019 New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019
News Conference News ESC 2019 Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2 Todd Neale September 04, 2019
News Conference News ESC 2019 Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT Michael O'Riordan September 03, 2019
News Conference News ESC 2019 Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events Michael O'Riordan September 02, 2019
News Conference News ESC 2019 MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds Shelley Wood September 02, 2019
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Conference News ESC 2019 Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS Michael O'Riordan September 01, 2019
News Conference News ESC 2019 DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics Shelley Wood September 01, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Conference News ESC 2019 POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients Michael O'Riordan August 31, 2019
News Conference News SCCT 2019 Time to Ease Up on Prior Authorization for PCSK9 Inhibitors? Yael L. Maxwell July 15, 2019
News Conference News SCCT 2019 Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology Yael L. Maxwell July 15, 2019
News Conference News TVT 2019 Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery Michael O'Riordan June 20, 2019
News Conference News TVT 2019 Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR Michael O'Riordan June 19, 2019
News Conference News TVT 2019 Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI Michael O'Riordan June 17, 2019
News Conference News TVT 2019 Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry Shelley Wood June 17, 2019
News Conference News TVT 2019 What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches? Michael O'Riordan June 14, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019